sults to differ materially from the results discussed in these
statements. Factors that might cause the company's results to differ
materially from those expressed or implied by such forward-looking
statements include, but are not limited to, the ability to discover,
develop and move target compounds into clinical development and other risks
and uncertainties detailed from time to time in the company's filings with
the Securities and Exchange Commission including its most recently filed
Form 10-Q and 10-K. SuperGen, Inc. undertakes no duty to update any of
these forward-looking statements to conform them to actual results.
Contacts
Timothy L. Enns Mary M. Vegh
SuperGen, Inc. SuperGen, Inc.
SVP, Corporate Communications Manager, Investor Relations
& Business Development Tel: (925) 560-2845
Tel: (925) 560-0100 E-mail: mary.vegh@supergen.com
E-mail: tenns@supergen.com
'/>"/>SOURCE SuperGen Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
Chennai AIDS Campaign Highlights The Social Neglect Faced By Victims2.
Benzene Slick In China Highlights Water Pollution 3.
India To Highlight Its Scientific Achievements4.
Homecare Association Highlights Cost-Effectiveness of Medicare and Medicaid5.
India To Highlight The Potential Role Of Ayurveda In London6.
Study Highlights Appetite Regulation Pathway, New Hope for Weight Loss7.
Study Highlights How Bacteria Respond To Changes In Environment8.
Drug Action Week to Highlight Effects of Alcohol9.
Clinton, Gates Highlight Treatment, Discrimination of AIDS10.
Highlights from World Transplant Congress11.
Latest IPCC Report Highlights Need for Integrated Climate/human Behavior Models